Lactam glycogen phosphorylase inhibitors and method of use
US7057046B2 · kind B2 · utility
15Cited by
57References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 2003 |
| Grant date | Jun 6, 2006 |
| Priority date | — |
| Expiry date | May 19, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula Iwherein Further provided is a method for treating diabetes and related diseases employing a glycogen phosphorylase inhibiting amount of the above compound, either alone or in combination with another therapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.